je.st
news
Tag: gilead
Biotech Short-Sellers Prefer Amgen To Gilead Sciences
2015-06-28 01:32:55| Biotech - Topix.net
Some of the biggest swings in short interest among the leading biotechs and emerging pharmaceuticals between the May 29 and June 15 settlement dates happened to Amgen, Inc. , Gilead Sciences, Inc. and Illumina, Inc. . Let's take a quick look at how these three stocks have fared recently and what analysts expect from them.
Tags: sciences
prefer
biotech
gilead
A new look at AIDS data, with an assist from Gilead
2015-06-27 05:00:57| Biotech - Topix.net
A map showing the prevalence of HIV/AIDS as closely as a census tract could help health care programs zero in on cities and even neighborhoods where they can focus their HIV treatment and prevention efforts. AIDSVu is a project of Emory University's Rollins School of Public Health in Atlanta in partnership with Gilead Sciences Inc. , the Foster City company that is the largest developer of HIV drugs.
Gilead: Still My Next Apple
2015-06-26 11:10:41| Biotech - Topix.net
I have been getting a lot of questions on Gilead Sciences over the past few weeks, as the biotech juggernaut has broken out from a long-term trading range. The stock is up some 50% since I penned an article highlighting its massive undervaluation a year ago, entitled "Why Gilead is my next Apple".
How Gilead Sciences Is Gouging Hepatitis C Patients, $1,000 a Pill
2015-06-21 20:06:31| Biotech - Topix.net
A new wave of hepatitis C drugs is all the rage. But while these new pills boast cure rates of 90 percent in less time than their predecessors, their prices are causing rage.
Tags: sciences
patients
pill
hepatitis
Gilead Sciences to Present at Two Upcoming Investor Conferences on...
2015-06-09 01:57:35| Biotech - Topix.net
Gilead Sciences, Inc. today announced that its corporate presentation will be webcast from two upcoming investor conferences: the Goldman Sachs 36th Annual Global Healthcare Conference in Rancho Palos Verdes and the William Blair 35th Annual Growth Stock Conference in Chicago. John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will provide an overview of the company at the Goldman Sachs conference on Tuesday, June 9 at 10:00 a.m. Pacific Time.
Tags: on
present
sciences
upcoming
Sites : [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] next »